Zinc-induced structural changes of the disordered tppp/p25 inhibits its degradation by the proteasome

A. Lehotzky, J. Oláh, Sándor Szunyogh, Adél Szabó, T. Berki, J. Ovádi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Tubulin Polymerization Promoting Protein/p25 (TPPP/p25), a neomorphic moonlighting protein displaying both physiological and pathological functions, plays a crucial role in the differentiation of the zinc-rich oligodendrocytes, the major constituent of myelin sheath; and it is enriched and co-localizes with α-synuclein in brain inclusions hallmarking Parkinson's disease and other synucleinopathies. In this work we showed that the binding of Zn2+ to TPPP/p25 promotes its dimerization resulting in increased tubulin polymerization promoting activity. We also demonstrated that the Zn2+ increases the intracellular TPPP/p25 level resulting in a more decorated microtubule network in CHO10 and CG-4 cells expressing TPPP/p25 ectopically and endogenously, respectively. This stabilization effect is crucial for the differentiation and aggresome formation under physiological and pathological conditions, respectively. The Zn2+-mediated effect was similar to that produced by treatment of the cells with MG132, a proteasome inhibitor or Zn2+ plus MG132 as quantified by cellular ELISA. The enhancing effect of zinc ion on the level of TPPP/p25 was independent of the expression level of the protein produced by doxycycline induction at different levels or inhibition of the protein synthesis by cycloheximide. Thus, we suggest that the zinc as a specific divalent cation could be involved in the fine-tuning of the physiological TPPP/p25 level counteracting both the enrichment and the lack of this protein leading to distinct central nervous system diseases.

Original languageEnglish
Pages (from-to)83-91
Number of pages9
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1852
Issue number1
DOIs
Publication statusPublished - Jan 1 2015

Fingerprint

Proteasome Endopeptidase Complex
Zinc
Tubulin
Polymerization
Proteins
Synucleins
Proteasome Inhibitors
Doxycycline
Central Nervous System Diseases
Oligodendroglia
Divalent Cations
Dimerization
Cycloheximide
Myelin Sheath
Microtubules
Parkinson Disease
Enzyme-Linked Immunosorbent Assay
Ions
Brain

Keywords

  • Oligodendrocyte
  • Tubulin polymerization promoting protein/p25
  • Zinc

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine
  • Medicine(all)

Cite this

@article{4af02f60adbe4cb78fa56e9df557c41c,
title = "Zinc-induced structural changes of the disordered tppp/p25 inhibits its degradation by the proteasome",
abstract = "Tubulin Polymerization Promoting Protein/p25 (TPPP/p25), a neomorphic moonlighting protein displaying both physiological and pathological functions, plays a crucial role in the differentiation of the zinc-rich oligodendrocytes, the major constituent of myelin sheath; and it is enriched and co-localizes with α-synuclein in brain inclusions hallmarking Parkinson's disease and other synucleinopathies. In this work we showed that the binding of Zn2+ to TPPP/p25 promotes its dimerization resulting in increased tubulin polymerization promoting activity. We also demonstrated that the Zn2+ increases the intracellular TPPP/p25 level resulting in a more decorated microtubule network in CHO10 and CG-4 cells expressing TPPP/p25 ectopically and endogenously, respectively. This stabilization effect is crucial for the differentiation and aggresome formation under physiological and pathological conditions, respectively. The Zn2+-mediated effect was similar to that produced by treatment of the cells with MG132, a proteasome inhibitor or Zn2+ plus MG132 as quantified by cellular ELISA. The enhancing effect of zinc ion on the level of TPPP/p25 was independent of the expression level of the protein produced by doxycycline induction at different levels or inhibition of the protein synthesis by cycloheximide. Thus, we suggest that the zinc as a specific divalent cation could be involved in the fine-tuning of the physiological TPPP/p25 level counteracting both the enrichment and the lack of this protein leading to distinct central nervous system diseases.",
keywords = "Oligodendrocyte, Tubulin polymerization promoting protein/p25, Zinc",
author = "A. Lehotzky and J. Ol{\'a}h and S{\'a}ndor Szunyogh and Ad{\'e}l Szab{\'o} and T. Berki and J. Ov{\'a}di",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.bbadis.2014.10.015",
language = "English",
volume = "1852",
pages = "83--91",
journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",
issn = "0925-4439",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Zinc-induced structural changes of the disordered tppp/p25 inhibits its degradation by the proteasome

AU - Lehotzky, A.

AU - Oláh, J.

AU - Szunyogh, Sándor

AU - Szabó, Adél

AU - Berki, T.

AU - Ovádi, J.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Tubulin Polymerization Promoting Protein/p25 (TPPP/p25), a neomorphic moonlighting protein displaying both physiological and pathological functions, plays a crucial role in the differentiation of the zinc-rich oligodendrocytes, the major constituent of myelin sheath; and it is enriched and co-localizes with α-synuclein in brain inclusions hallmarking Parkinson's disease and other synucleinopathies. In this work we showed that the binding of Zn2+ to TPPP/p25 promotes its dimerization resulting in increased tubulin polymerization promoting activity. We also demonstrated that the Zn2+ increases the intracellular TPPP/p25 level resulting in a more decorated microtubule network in CHO10 and CG-4 cells expressing TPPP/p25 ectopically and endogenously, respectively. This stabilization effect is crucial for the differentiation and aggresome formation under physiological and pathological conditions, respectively. The Zn2+-mediated effect was similar to that produced by treatment of the cells with MG132, a proteasome inhibitor or Zn2+ plus MG132 as quantified by cellular ELISA. The enhancing effect of zinc ion on the level of TPPP/p25 was independent of the expression level of the protein produced by doxycycline induction at different levels or inhibition of the protein synthesis by cycloheximide. Thus, we suggest that the zinc as a specific divalent cation could be involved in the fine-tuning of the physiological TPPP/p25 level counteracting both the enrichment and the lack of this protein leading to distinct central nervous system diseases.

AB - Tubulin Polymerization Promoting Protein/p25 (TPPP/p25), a neomorphic moonlighting protein displaying both physiological and pathological functions, plays a crucial role in the differentiation of the zinc-rich oligodendrocytes, the major constituent of myelin sheath; and it is enriched and co-localizes with α-synuclein in brain inclusions hallmarking Parkinson's disease and other synucleinopathies. In this work we showed that the binding of Zn2+ to TPPP/p25 promotes its dimerization resulting in increased tubulin polymerization promoting activity. We also demonstrated that the Zn2+ increases the intracellular TPPP/p25 level resulting in a more decorated microtubule network in CHO10 and CG-4 cells expressing TPPP/p25 ectopically and endogenously, respectively. This stabilization effect is crucial for the differentiation and aggresome formation under physiological and pathological conditions, respectively. The Zn2+-mediated effect was similar to that produced by treatment of the cells with MG132, a proteasome inhibitor or Zn2+ plus MG132 as quantified by cellular ELISA. The enhancing effect of zinc ion on the level of TPPP/p25 was independent of the expression level of the protein produced by doxycycline induction at different levels or inhibition of the protein synthesis by cycloheximide. Thus, we suggest that the zinc as a specific divalent cation could be involved in the fine-tuning of the physiological TPPP/p25 level counteracting both the enrichment and the lack of this protein leading to distinct central nervous system diseases.

KW - Oligodendrocyte

KW - Tubulin polymerization promoting protein/p25

KW - Zinc

UR - http://www.scopus.com/inward/record.url?scp=84912017655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912017655&partnerID=8YFLogxK

U2 - 10.1016/j.bbadis.2014.10.015

DO - 10.1016/j.bbadis.2014.10.015

M3 - Article

C2 - 25445539

AN - SCOPUS:84912017655

VL - 1852

SP - 83

EP - 91

JO - Biochimica et Biophysica Acta - Molecular Basis of Disease

JF - Biochimica et Biophysica Acta - Molecular Basis of Disease

SN - 0925-4439

IS - 1

ER -